These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27040814)

  • 1. Pharmacokinetic and pharmacodynamic study of a phospholipid-based phase separation gel for once a month administration of octreotide.
    Wang M; Shan F; Zou Y; Sun X; Zhang ZR; Fu Y; Gong T
    J Control Release; 2016 May; 230():45-56. PubMed ID: 27040814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high-efficiency, low-toxicity, phospholipids-based phase separation gel for long-term delivery of peptides.
    Zhang T; Peng Q; San FY; Luo JW; Wang MX; Wu WQ; Gong T; Zhang ZR
    Biomaterials; 2015 Mar; 45():1-9. PubMed ID: 25662489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable and biodegradable phospholipid-based phase separation gel for sustained delivery of insulin.
    Zhang T; Luo J; Peng Q; Dong J; Wang Y; Gong T; Zhang Z
    Colloids Surf B Biointerfaces; 2019 Apr; 176():194-201. PubMed ID: 30616110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymopentin-loaded phospholipid-based phase separation gel with long-lasting immunomodulatory effects: in vitro and in vivo studies.
    Zhang T; Qin XY; Cao X; Li WH; Gong T; Zhang ZR
    Acta Pharmacol Sin; 2019 Apr; 40(4):514-521. PubMed ID: 30002492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of liver cancer in mice by the intratumoral injection of an octreotide-based temperature‑sensitive gel.
    Zhang L; Yu S; Duan Z; Wang Q; Tian G; Tian Y; Zhao W; Wang H; Zhang C; Guo S; Liu Q; He G; Bian T; Chang J; Jin X; Cui D
    Int J Mol Med; 2014 Jan; 33(1):117-27. PubMed ID: 24173662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.
    Bevan JS; Atkin SL; Atkinson AB; Bouloux PM; Hanna F; Harris PE; James RA; McConnell M; Roberts GA; Scanlon MF; Stewart PM; Teasdale E; Turner HE; Wass JA; Wardlaw JM
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4554-63. PubMed ID: 12364434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteers.
    Tiberg F; Roberts J; Cervin C; Johnsson M; Sarp S; Tripathi AP; Linden M
    Br J Clin Pharmacol; 2015 Sep; 80(3):460-72. PubMed ID: 26076191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma.
    Hua YP; Yin XY; Peng BG; Li SQ; Lai JM; Liang HZ; Liang LJ
    Chemotherapy; 2009; 55(5):312-20. PubMed ID: 19590186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ Preparation of a Phospholipid Gel Co-Loaded with Methotrexate and Dexamethasone for Synergistic Rheumatoid Arthritis Treatment.
    Pu Q; Wang K; Peng B; Chen K; Gong T; Liu F; Yang Q
    Int J Nanomedicine; 2022; 17():5153-5162. PubMed ID: 36348765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.
    Yuen MF; Poon RT; Lai CL; Fan ST; Lo CM; Wong KW; Wong WM; Wong BC
    Hepatology; 2002 Sep; 36(3):687-91. PubMed ID: 12198662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone Phospholipid Gel for Intramuscular Administration Prepared by In Situ-Phase Separation.
    Dong N; Tang L; Zhao M; Zhang Y; Zhang Y; Yin T; He H; Gou J; Yuan Y; Tang X
    AAPS PharmSciTech; 2022 Nov; 23(8):294. PubMed ID: 36329305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly.
    Colao A; Ferone D; Marzullo P; Cappabianca P; Cirillo S; Boerlin V; Lancranjan I; Lombardi G
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2779-86. PubMed ID: 11397887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An injectable, low-toxicity phospholipid-based phase separation gel that induces strong and persistent immune responses in mice.
    Han L; Xue J; Wang L; Peng K; Zhang Z; Gong T; Sun X
    Biomaterials; 2016 Oct; 105():185-194. PubMed ID: 27522253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic evidence for developing an oral formulation of octreotide against gastric mucosal injury.
    Li XN; Rao T; Xu YF; Hu KR; Zhu ZP; Li HF; Kang D; Shao YH; Shen BY; Yin XX; Xie L; Wang GJ; Liang Y
    Acta Pharmacol Sin; 2018 Aug; 39(8):1373-1385. PubMed ID: 29188801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Injectable Gel Platform for the Prolonged Therapeutic Effect of Pitavastatin in the Management of Hyperlipidemia.
    Xiang N; Zhou X; He X; Zhang Y; Zhang J; Zhang ZR; Sun X; Gong T; Fu Y
    J Pharm Sci; 2016 Mar; 105(3):1148-55. PubMed ID: 26886326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide.
    Erfani Jabarian L; Rouini MR; Atyabi F; Foroumadi A; Nassiri SM; Dinarvand R
    Eur J Pharm Sci; 2013 Jan; 48(1-2):87-96. PubMed ID: 23131800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of sandostatin LAR in treating patients with advanced hepatocellular cancer.
    Dimitroulopoulos D; Xinopoulos D; Tsamakidis K; Zisimopoulos A; Andriotis E; Markidou S; Panagiotakos D; Chrysohoou C; Bazinis A; Paraskevas E
    Hepatogastroenterology; 2002; 49(47):1245-50. PubMed ID: 12239914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of Three-Phase Drug Release Mode of Octreotide PLGA Microspheres by Microsphere-Gel Composite System.
    Wang T; Zhang C; Zhong W; Yang X; Wang A; Liang R
    AAPS PharmSciTech; 2019 Jun; 20(6):228. PubMed ID: 31227940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced anti-tumor and anti-metastasis efficacy against breast cancer with an intratumoral injectable phospholipids-based phase separation gel co-loaded with 5-fluotouracil and magnesium oxide by neutralizing acidic microenvironment.
    Yang L; Song X; Gong T; Wang L; Zhao T; Li L; Zhou C; Sun X; Zhang Z; Gong T
    Int J Pharm; 2018 Aug; 547(1-2):181-189. PubMed ID: 29864512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of a cohort of 63 patients with hepatocellular carcinoma treated with octreotide.
    Rabe C; Pilz T; Allgaier HP; Halm U; Strasser C; Wettstein M; Sauerbruch T; Caselmann WH
    Z Gastroenterol; 2002 Jun; 40(6):395-400. PubMed ID: 12055662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.